Alessio Bloesch Email

Director Clinical Education and Product Innovation . Aethlon Medical

Current Roles

Employees:
28
Revenue:
$3.5M
About
Aethlon Medical develops therapeutic devices that treat HIV/AIDS, Hepatitis-C, and other infectious diseases. In pre-clinical testing, Aethlon's lead product, AEMD-45 removes 55% of HIV from human blood in three hours and in excess of 85% in twelve hours. The AEMD-45 therapeutic device, like all product offerings from Aethlon Medical, is developed from an expansive platform technology known as the Hemopurifier(TM), which employs a proprietary method to increase the capability of FDA cleared artificial kidneys (hemodialysis cartridges) to remove targeted intoxicants from the blood. In the case of AEMD-45, dialysis cartridges are modified to mimic the immune system's response to clear infectious virus from circulation before healthy cells are infected. AEMD-45 is designed to fill the urgent need for new treatments that are effective in reducing viral load, decrease the likelihood of treatment resistance, and treat without the toxic side-effects associated with AIDS drugs.
Aethlon Medical Address
9635 Granite Ridge Drive
San Diego, CA
United States
Aethlon Medical Email

Past Companies

Aethlon Medical, Inc.Director of Clinical Education and Product Innovation
Scripps HealthIntensive Care Nurse
Scripps Mercy HospitalVolunteer in ICU

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.